Home World News Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon... World News Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer By Ogkologos - July 30, 2026 170 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CIRCULATE, an AIO (KRK-0217)/ABCSG study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical... October 3, 2025 Exceptional Response Rates and Survival Among Patients with POLE/D1 Proofreading Deficient... May 31, 2024 3…2…1…Countdown to Medicare Open Enrollment October 12, 2023 Uncle Charlie’s Promise February 23, 2021 Load more HOT NEWS Nanoparticle Trains Immune Cells to Attack Cancer The Impact of COVID-19 on Black and Hispanic People with Cancer:... 24% of Breast Cancers Diagnosed Between Mammograms Could Have Been Detected... Group Dressed as Breasts Gathers to Protest Facebook’s Censorship of Areola...
